NSC |
Compound |
Enrichment |
Correlation |
NSC 726364 |
Null |
0.0403978426119741 |
0.29132447 |
NSC 732737 |
Null |
0.0403978426119741 |
0.20576943 |
NSC 732825 |
N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide |
0.0403978426119741 |
0.23658614 |
NSC 741106 |
6-(3-Aminopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.0403978426119741 |
0.6642922 |
NSC 746930 |
Null |
0.0403978426119741 |
0.28449043 |
NSC 748643 |
Mitaplatin |
0.0403978426119741 |
0.48697471 |
NSC 759878 |
Irinotecan hydrochloride (USAN) |
0.0403978426119741 |
0.83433287 |
NSC 88916 |
10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
0.0403978426119741 |
0.2398405 |
NSC 670678 |
Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester |
0.0404100698195776 |
-0.15343222 |
NSC 112152 |
2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) |
0.0421163101172308 |
0.11244653 |